Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing

Journal of Endocrinological Investigation

Volumn 31, Issue 10, 2008, Pages 888-892

  Cecoli, F ^a   Andraghetti, G ^a   Ghiara, C ^a   Briatore, L ^a   Cavallero, D ^a   Mussap, M ^a   Minuto, F ^a   Giusti, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Differentiated thyroid carcinoma; Leptin; rhTSH

Indexed keywords

LEPTIN; LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; BODY MASS; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIFFERENTIATED THYROID CARCINOMA; FEMALE; HORMONE DETERMINATION; HUMAN; IN VIVO STUDY; LABORATORY TEST; LIPID METABOLISM; PROTEIN BLOOD LEVEL; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID HORMONE BLOOD LEVEL; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT FAILURE;

EID: 58649086532     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346437     Document Type: Article

References (28)

1. Dhillo WS. Appetite regulation: an overview. Thyroid 2007, 17: 433-45.
2. Feldt-Rasmussen U. Thyroid and leptin. Thyroid 2007, 17: 413-9.
3. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weight reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Enclocrinol Metab 2002, 87: 2391-4.
4. Kok P, Roelfsema F, Langendonk JG, et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab 2005, 90: 4659-63.
5. lacobellis G, Ribaudo MC, Zappaterreno A, lannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 2005, 62: 487-91.
6. Michalaki MA, Vagenakis AG, Leonardou AS, et al. Thyroid function in humans with morbid obesity. Thyroid 2006, 16: 73-8.
7. Tene Pérez CE, Revilla-Monsalve MC, Amato D, et al. Correlation between serum leptin levels and insulin sensitivity in diffuse toxic goiter. Endocr Res 2004, 30: 19-27.
8. Röjdmark S, Calissendorff J, Danielsson O, Brismar K. Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 2005, 27: 55-61.
9. Iglesias P, Alvarez Fidalgo P, Codoceo R, Díez JJ. Serum concentration of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 2003, 59: 621-9.
10. Oge A, Bayraktar F, Saygili F, Guney E, Demir S. TSH influences serum leptin levels independent of thyroid hormones in hypothyroid and hyperthyroid patients. Endocr J 2005, 52: 213-7,
11. Baig M, Azhar A, Zaidi P, Kamal S, Karira K. Serum leptin levels in hypothyroid males. J Coll Physicians Surg Pak 2005, 15: 757-60.
12. Menendez C, Baldelli R, Camina JP, et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol 2003, 176: 7-12.
13. Antunes TT, Gagnon A, Chen B, Pacini F, Smith TJ, Sorisky A. Interleukin-6 release from human adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot. Am J Physiol Enclocrinol Metab 2006, 290: E1140-4.
14. Agretti P, De Marco G, De Servi M, et al. Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after aclipocytic differentiation. Eur J Endocrinol 2005, 152: 777-84.
15. Giusti M, Cappi C, Augeri C, Cavallero D, Molinari E, Minuto F. Recombinant human TSH (rh-TSH) testing after short-term L-thyroxine (L-T4) reduction: a sensitising test to confirm a disease-free state in papillary thyroid carcinoma (PTC). 12th International Congress of Endocrinology, Lisbon, August 31 -September 4 2004, pp. 259-60
16. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS. Clinical impact of thyrogloloulin (Tg) and Tg autoantiloody method differences on the management of patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2005, 90: 5566-75.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9.
18. Torlontano M, Attard M, Crocetti U, et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Chin Endocrinol Metab 2004, 89: 3402-7.
19. Giusti M, Zoccola R, Guazzini B, et al. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience. Min Endocrinol 2003, 28: 191-203.
20. Sellitti DF, Dennison D, Akamizu T, Doi SQ, Kohn LD, Koshiyama H. Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells. Thyroid 2000, 10: 219-25.
21. Davies TF, Marians R, Latif R. The TSH receptor reveals itself. J Clin Invest 2002, 110: 161-4.
22. Giusti M, Valenti S, Guazzini B, et al. Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant. J Endocrinol Invest 2003, 26: 1192-7.
23. Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodelling. Cell 2003, 115: 151-62.
24. Mazziotti G, Sorvillo F, Piscopo M, et al. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res 2005, 20: 480-6.
25. Giusti M, Cecoli F, Ghiara C, et al. Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-ka ppa Beta ligand in patients under evaluation for differentiated thyroid carcinoma. Hormones (Athens) 2007, 6: 304-13.
26. Mantzoros CS, Ozata M, Negrao AB, et al. Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Enclocrinol Metab 2001, 86: 3284-91.
27. Mantzoros CS, Moschos SJ. Leptin: in search of role(s) in hurnan physiology and pathophysiology. Clin Endocrinol (Oxf) 1998, 49: 551-67.
28. Zanotti-Fregonara P, Duron F, Keller I, Khoury A, Devaux JY, Hindié E. Stimulation test in the follow-up of thyroid cancer: plasma rhTSH levels are dependent on body weight, not endogenously stimulated TSH values. Nucl Med Commun 2007, 28: 257-9.